Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

CUSIP: 09073Q105

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
-10,314
SEC-reported price per share
$1.66
Number of holders
15
Value change
-$97,445
Number of buys
9
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
592,878

Security key

09073Q105

Report period

Q1 2022

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
STATE STREET CORP
Disclosed value leader
STATE STREET CORP
Comparable rows
13/13
Latest evidence
31 Dec 2021
13F Lead comparable stake: 14% Showing 1-6 of 13 holder rows.

Quick read

STATE STREET CORP leads the comparable SEC ownership view at 14%.

13 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens STATE STREET CORP's linked filing trail.
Comparable ownership Top 5
STATE STREET CORP 14%
ENVESTNET ASSET MANAGEMENT INC 8.4%
TWO SIGMA SECURITIES, LLC 8.3%
TRUE Private Wealth Advisors 7.8%
MORGAN STANLEY 7.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 13 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
STATE STREET CORP
13F
Company
13F
14%
$200,000
85,181 shares
31 Dec 2021
ENVESTNET ASSET MANAGEMENT INC
13F
Company
13F
8.4%
$118,000
50,005 shares
31 Dec 2021
TWO SIGMA SECURITIES, LLC
13F
Company
13F
8.3%
$116,000
49,440 shares
31 Dec 2021
TRUE Private Wealth Advisors
13F
Company
13F
7.8%
$108,000
46,000 shares
31 Dec 2021
MORGAN STANLEY
13F
Company
13F
7.4%
$103,000
43,623 shares
31 Dec 2021
ExodusPoint Capital Management, LP
13F
Company
13F
5.3%
$74,000
31,500 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
328,283
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
15
Q1 2022 holders
15
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .